Republican senators slam proposed accelerated approval payment reforms
Republican senators are speaking out against a proposed test model in which drugmakers would effectively make less for drugs approved via the FDA’s accelerated approval.
The test program, dubbed the Accelerating Clinical Evidence Model, was announced last month as a way to incentivize quicker confirmatory trials and “reduce Medicare spending on drugs that have no confirmed clinical benefit.” HHS Secretary Xavier Becerra directed CMS to begin consultation with the FDA on the model this year.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.